Vol 3, No 2 (February 15, 2015): Annals of Translational Medicine

Editorial

The burning questions of heterotopic ossification
Chen Kan, Lixin Kan
Annals of Translational Medicine  
2015;
3
(2)
:14
.
Research, evidence, and ethics: new technology or grey medicine
Haoran Zhai, Wenzhao Zhong, Yilong Wu
Annals of Translational Medicine  
2015;
3
(2)
:15
.
Significance of 99mTc-GSA liver scintigraphy in liver surgery and transplantation
Taku Iida, Shintaro Yagi, Tomohide Hori, Shinji Uemoto
Annals of Translational Medicine  
2015;
3
(2)
:16
.
99mTc-GSA SPECT/CT fused images for assessment of hepatic function and hepatectomy planning
Morikatsu Yoshida, Toru Beppu, Shinya Shiraishi, Noriko Tsuda, Fumi Sakamoto, Hirohisa Okabe, HIromitsu Hayashi, Hideo Baba, Yasuyuki Yamashita
Annals of Translational Medicine  
2015;
3
(2)
:17
.
Will the 40-gene expression classifier predict responders to EGFR targeted chemotherapy for the invasive bladder cancer patients?
Jayoung Kim, Wun-Jae Kim
Annals of Translational Medicine  
2015;
3
(2)
:18
.
Optimizing lung cancer screening: nodule size, volume doubling time, morphology and evaluation of other diseases
Firdaus A. A. Mohamed Hoesein, Pim A. de Jong, Onno M. Mets
Annals of Translational Medicine  
2015;
3
(2)
:19
.
New therapies for reducing post-myocardial left ventricular remodeling
Robert A. Kloner, Jianru Shi, Wangde Dai
Annals of Translational Medicine  
2015;
3
(2)
:20
.
Probability of lung cancer based on the size threshold and volume-doubling time for lung nodules detected in low-dose CT screening
Hyun Lee, Sang-Won Um
Annals of Translational Medicine  
2015;
3
(2)
:21
.

Original Article

Glucan supplementation enhances the immune response against an influenza challenge in mice
Vaclav Vetvicka, Jana Vetvickova
Annals of Translational Medicine  
2015;
3
(2)
:22
.
The role of chemokine receptor 4 and its ligand stromal cell derived factor 1 in breast cancer
Binu Kottakkal Aravindan, Jem Prabhakar, Thara Somanathan, Lakshmi Subhadra
Annals of Translational Medicine  
2015;
3
(2)
:23
.

Review Article

Impact of BRAF mutation status in the prognosis of cutaneous melanoma: an area of ongoing research
Parisha Bhatia, Paul Friedlander, Elmageed A Zakaria, Emad Kandil
Annals of Translational Medicine  
2015;
3
(2)
:24
.

Perspective

Surgery or stereotactic ablative radiation therapy: how will be treated operable patients with early stage not small cell lung cancer in the next future?
Luca Bertolaccini, Alberto Terzi, Francesco Ricchetti, Filippo Alongi
Annals of Translational Medicine  
2015;
3
(2)
:25
.

The Voice of the Patient

Lung cancer is a global epidemic and requires a global effort
Bonnie J. Addario
Annals of Translational Medicine  
2015;
3
(2)
:26
.

Meet the Professor1

Prof. Jacek Jassem: we should be more aggressive about tobacco control in fighting against lung cancer
Grace S. Li
Annals of Translational Medicine  
2015;
3
(2)
:27
.

News

The voice of the patient: a venue for all of our voices in Annals of Translational Medicine
Grace S. Li
Annals of Translational Medicine  
2015;
3
(2)
:28
.

Disclosure:

1. The series “Meet the Professor” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding.